Earnings

Royalty Pharma published press releases by date and/or category

Royalty Pharma Announces Dividend Increase

NEW YORK, NY, January 9, 2025 – Royalty Pharma plc (Nasdaq: RPRX) today announced that its board of directors has declared a dividend for the first quarter of 2025 of $0.22 per Class A ordinary share, reflecting a 5% increase in the company’s quarterly dividend over the previous quarter’s dividend.

Stay up to date

Subscribe to Royalty Pharma news and alerts

Subscribe